Tavaborole
CAS 174671-46-6
Overview
Tavaborole, sold under the brand name Kerydin, is a topical antifungal medication for the treatment of onychomycosis, a fungal infection of the nail and nail bed. Tavaborole was approved by the US FDA in July 2014
Anant Labs manufacture and furnish high quality Tavaborole impurities for global markets. Our Tavaborole EP Impurities are used by API manufacturers and fully integrated pharmaceutical companies worldwide.
Technical Data
CAS174671-46-6
Mol. FormulaC7H6BFO2
Mol. Weight151.933 g/mol
IUPAC5-fluoro-1-hydroxy-3H-2,1-benzoxaborole
SMILESB1(C2=C(CO1)C=C(C=C2)F)O
InChIInChI=1S/C7H6BFO2/c9-6-1-2-7-5(3-6)4-11-8(7)10/h1-3,10H,4H2
InChI KeyLFQDNHWZDQTITF-UHFFFAOYSA-N
Note: We are upgrading our system, Cat No will change.
Synonyms
Tavaborole174671-46-6AN-2690Kerydin2,1-Benzoxaborole, 5-fluoro-1,3-dihydro-1-hydroxy-AN2690AN 26905-Fluoro-1,3-dihydro-1-hydroxy-2,1-benzoxaboroletavaborolSCH-900340
